Details for Patent: 9,403,799
✉ Email this page to a colleague
Which drugs does patent 9,403,799 protect, and when does it expire?
Patent 9,403,799 protects TEPMETKO and is included in one NDA.
This patent has seventy-six patent family members in thirty-five countries.
Summary for Patent: 9,403,799
| Title: | Pyrimidinyl-pyridazinone derivatives for treating a disease which is influenced by inhibition of met kinase |
| Abstract: | Compounds selected from the group according to claim 1 are inhibitors of tyrosine kinases, in particular of Met kinase, and can be employed, inter alia, for the treatment of tumors. |
| Inventor(s): | Schadt; Oliver (Rodenbach, DE), Dorsch; Dieter (Ober-Ramstadt, DE), Stieber; Frank (Heidelberg, DE), Blaukat; Andree (Schriesheim, DE) |
| Assignee: | MERCK PATENT GMBH (Darmstadt, DE) |
| Application Number: | 14/602,921 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; |
Drugs Protected by US Patent 9,403,799
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Emd Serono Inc | TEPMETKO | tepotinib hydrochloride | TABLET;ORAL | 214096-001 | Feb 3, 2021 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | TREATING A SOLID TUMOR, INCLUDING LUNG CANCER, WITH A MET ALTERATION(S), OR STABILIZING OR IMPROVING SYMPTOMS ASSOCIATED WITH HAVING A SOLID TUMOR, INCLUDING LUNG CANCER, WITH A MET ALTERATION(S), BY ADMINISTERING AN EFFECTIVE AMOUNT OF TEPOTINIB | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,403,799
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2164843 | ⤷ Sign Up | C02164843/01 | Switzerland | ⤷ Sign Up |
| European Patent Office | 2164843 | ⤷ Sign Up | 301176 | Netherlands | ⤷ Sign Up |
| European Patent Office | 2164843 | ⤷ Sign Up | PA2022009 | Lithuania | ⤷ Sign Up |
| European Patent Office | 2164843 | ⤷ Sign Up | 2022C/519 | Belgium | ⤷ Sign Up |
| European Patent Office | 2164843 | ⤷ Sign Up | LUC00264 | Luxembourg | ⤷ Sign Up |
| European Patent Office | 2164843 | ⤷ Sign Up | CA 2022 00021 | Denmark | ⤷ Sign Up |
| European Patent Office | 2164843 | ⤷ Sign Up | 122022000047 | Germany | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
